Unfavorable prognosis of elderly patients with early-stage extranodal nasal-type NK/T-cell lymphoma
- 1 February 2011
- journal article
- research article
- Published by Elsevier BV in Annals Of Oncology
- Vol. 22 (2), 390-396
- https://doi.org/10.1093/annonc/mdq347
Abstract
Extranodal nasal-type NK (natural killer)/T-cell lymphoma in elderly patients is rare, and its prognosis is unclear. This study aims to investigate the clinical characteristics and prognosis of this lymphoma. We analyzed 24 patients (age, >60 years old) with early-stage extranodal nasal-type NK/T-cell lymphoma. Among these patients, 23 received radiotherapy alone (n = 15) or radiotherapy and chemotherapy (n = 8) and 1 received chemotherapy alone. Elderly patients with early-stage extranodal nasal-type NK/T-cell lymphoma were characterized by male predominance, good performance, large proportion of localized disease, more comorbidities, low-risk international prognostic index, and unfavorable prognosis. The 5-year cancer-specific survival (CSS), overall survival (OS), and progression-free survival (PFS) rates for all patients were 54.3%, 42.0%, and 40.2%, respectively. The 5-year CSS, OS, and PFS rates were 43.5%, 36.6%, and 34.1% in patients who received radiotherapy alone, and 50%, 50%, and 50% in patients who received radiotherapy and chemotherapy, respectively (P = 0.852 for CSS, P = 0.801 for OS, and P = 0.694 for PFS). Four patients died of treatment-related mortality. Elderly patients with early-stage extranodal nasal-type NK/T-cell lymphoma exhibit poor prognosis and need special attention because of high treatment-related mortality.Keywords
Funding Information
- National Natural Science Foundation of China (30870736)
This publication has 41 references indexed in Scilit:
- Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma ProjectBlood, 2009
- International Peripheral T-Cell and Natural Killer/T-Cell Lymphoma Study: Pathology Findings and Clinical OutcomesJournal of Clinical Oncology, 2008
- Clinical heterogeneity of extranodal NK/T-cell lymphoma, nasal type: a national survey of the Korean Cancer Study GroupAnnals Of Oncology, 2008
- Early or Up-Front Radiotherapy Improved Survival of Localized Extranodal NK/T-Cell Lymphoma, Nasal-Type in the Upper Aerodigestive TractInternational Journal of Radiation Oncology*Biology*Physics, 2007
- Extranodal NK/T-cell Lymphoma, Nasal Type: Study of Clinicopathologic and Prognosis Factors in a Series of 78 Cases From PeruApplied Immunohistochemistry & Molecular Morphology, 2007
- Expression of the granzyme B inhibitor PI9 predicts outcome in nasal NK/T-cell lymphoma: results of a Western series of 48 patients treated with first-line polychemotherapy within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trialsBlood, 2006
- Radiotherapy As Primary Treatment for Stage IE and IIE Nasal Natural Killer/T-Cell LymphomaJournal of Clinical Oncology, 2006
- Treatment outcome and pattern of failure in 77 patients with sinonasal natural killer/T‐cell or T‐cell lymphomaCancer, 2004
- Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic IndexBlood, 2004
- Combined chemotherapy and radiation versus radiation alone in the management of localized angiocentric lymphoma of the head and neckRadiotherapy and Oncology, 2001